House cats are getting their tumours mapped, and it may help human patients

Researchers sequenced 493 tumour samples from pet cats in five countries, covering 13 cancer types, and found that the genetic drivers of feline cancer overlap with those of human cancer. The mapping, published in Science on February 19, 2026, is described by its authors as the first large-scale genetic map of cat cancer, and they say it may help people as well as cats.

493 tumours, 13 cancers, five countries

The project was led by the Wellcome Sanger Institute in Cambridge, England, with the Ontario Veterinary College at the University of Guelph, the University of Bern and Cornell University’s College of Veterinary Medicine among the partners. Veterinarians collected the samples from pet cats, which is the point of the design: these are tumours from animals living in ordinary homes, not tumours induced in laboratory animals. Cornell describes the result as the first large-scale genetic map of feline cancer, and the five countries are what give the collection its breadth.

The team sequenced roughly 1,000 genes known to be involved in human cancer and searched for driver mutations, the changes that push a cell toward becoming a tumour. The paper, titled “The oncogenome of the domestic cat,” reports that the most frequently mutated gene across the feline tumours was TP53, altered in 33 percent of them, according to Cornell’s summary. In human cancers the same gene is mutated at nearly the same rate, 34 percent.

FBXW7 and the cat mammary tumour

The sharpest comparison concerns mammary carcinoma, the feline equivalent of breast cancer. The Sanger team identified seven driver genes in these tumours. FBXW7 was mutated in more than half of them, and PIK3CA in 47 percent, as the Sanger release reports. Both genes are also involved in human breast cancer, where FBXW7 mutations are associated with a worse prognosis and PIK3CA changes can be treated with PI3K inhibitors.

The University of Bern, which says it led the international team, adds a twist from its own side of the work. Feline mammary tumours frequently carried FBXW7 mutations rather than the BRCA1 changes that might be expected from the human picture, and some genetic changes occurred more often at identical positions in the cat and human genomes, according to PhD student Chang He in the Bern release.

Parallels with human disease appeared beyond the mammary gland, in blood, bone, lung, skin, gastrointestinal and central nervous system cancers. Cutaneous squamous cell carcinoma in cats showed an association with ultraviolet radiation resembling that in human skin cancer, which Cornell lists among the cross-species similarities the data revealed across those cancer types.

Drug tests and the limits of “may help”

The nearest the study comes to patients is a laboratory test. The Bern team exposed three-dimensional cultures of feline mammary tumour cells, called tumoroids, to vinca alkaloid chemotherapy drugs and found the drugs markedly more effective in tumoroids carrying FBXW7 mutations than in those without them. Sven Rottenberg, a co-senior author, said access to such a large set of donated tissue made it possible to assess drug responses across tumour types at a scale not previously achievable.

The authors do not present this as a treatment, and the chain from a dish of cells to a clinic is long. The release language is that the tissue-culture findings require further investigation, and they were not a clinical trial in cats or people. A drug that works better in a dish of mutant cat tumour cells has not been shown to help a cat patient, still less a human one. That is why the study’s own framing is potential: genetic overlap makes cats a plausible comparison model, and no more than that has been demonstrated.

Even so, the paper gives researchers a shared reference. Where a cat tumour and a human tumour carry the same altered gene, findings in one species can be tested in the other, which is the practical sense in which the work may help human patients.

The researchers frame the work under a “One Medicine” idea in which veterinary and human medicine inform each other. Louise Van Der Weyden of the Sanger Institute and Geoffrey Wood of the Ontario Veterinary College are among the named authors, and Wood noted that household pets share living spaces with their owners, which offers a way to study how shared environments may influence cancer risk. Latasha Ludwig of Cornell said information found in people can be translated to cats, and knowledge can flow from cats to people as well.

A lasting resource also came out of the study: a freely available database of feline cancer genetics intended for other researchers, per the EurekAlert posting of the Sanger release. A veterinary trade report on the paper gives its title and the same list of partner institutions. What the database ultimately contributes to human oncology depends on follow-up work that has yet to be reported.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.